{"id":925,"date":"2014-12-10T16:32:05","date_gmt":"2014-12-10T15:32:05","guid":{"rendered":"http:\/\/www.universalmedica.com\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/"},"modified":"2014-12-10T16:32:05","modified_gmt":"2014-12-10T15:32:05","slug":"ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france","status":"publish","type":"post","link":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/","title":{"rendered":"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France."},"content":{"rendered":"<h3 style=\"text-align: justify;\"><b>L\u2019ANSM lance une proc\u00e9dure de suspension, \u00e0 compter du 18 d\u00e9cembre, de 25 m\u00e9dicaments commercialis\u00e9s en France.<\/b><\/h3>\n<p style=\"text-align: justify;\">Une inspection par l\u2019ANSM d\u2019un site de la soci\u00e9t\u00e9 GVK Bio qui r\u00e9alise des essais cliniques parmi lesquels des essais de bio\u00e9quivalence en Inde, a mis en \u00e9vidence des irr\u00e9gularit\u00e9s dans des documents associ\u00e9s \u00e0 ces essais sur lesquels s\u2019appuient les AMM (autorisation de mise sur le march\u00e9) de plusieurs m\u00e9dicaments.<\/p>\n<p style=\"text-align: justify;\">L\u2019ANSM a d\u00e9cid\u00e9, par mesure de pr\u00e9caution, de suspendre les AMM de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s.<\/p>\n<p style=\"text-align: justify;\">Les autorit\u00e9s europ\u00e9ennes ont \u00e9t\u00e9 saisies par la France et, dans l\u2019attente de leur d\u00e9cision finale,\u00a0 l\u2019Allemagne,\u00a0 la Belgique et le Luxembourg ont \u00e9galement d\u00e9cid\u00e9 de suspendre les AMM des m\u00e9dicaments concern\u00e9s.<\/p>\n<h3 style=\"text-align: justify;\"><b><\/b><b>Universal Medica, leader europ\u00e9en en Information et Communication M\u00e9dicale et Scientifique, accompagne les laboratoires dans la gestion de crise.<\/b><\/h3>\n<p style=\"text-align: center;\"><a href=\"mailto:aurelia.ringard@universalmedica.com\"><img decoding=\"async\" class=\"size-full wp-image-2453 aligncenter\" alt=\"contact\" src=\"http:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/04\/contact.png\" width=\"245\" height=\"96\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019ANSM lance une proc\u00e9dure de suspension, \u00e0 compter du 18 d\u00e9cembre, de 25 m\u00e9dicaments commercialis\u00e9s en France. Une inspection par l\u2019ANSM d\u2019un site de la soci\u00e9t\u00e9 GVK Bio qui r\u00e9alise des essais cliniques parmi lesquels des essais de bio\u00e9quivalence en Inde, a mis en \u00e9vidence des irr\u00e9gularit\u00e9s dans des documents associ\u00e9s \u00e0 ces essais sur [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":635,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France. - Universal Medica<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France. - Universal Medica\" \/>\n<meta property=\"og:description\" content=\"L\u2019ANSM lance une proc\u00e9dure de suspension, \u00e0 compter du 18 d\u00e9cembre, de 25 m\u00e9dicaments commercialis\u00e9s en France. Une inspection par l\u2019ANSM d\u2019un site de la soci\u00e9t\u00e9 GVK Bio qui r\u00e9alise des essais cliniques parmi lesquels des essais de bio\u00e9quivalence en Inde, a mis en \u00e9vidence des irr\u00e9gularit\u00e9s dans des documents associ\u00e9s \u00e0 ces essais sur [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/\" \/>\n<meta property=\"og:site_name\" content=\"Universal Medica\" \/>\n<meta property=\"article:published_time\" content=\"2014-12-10T15:32:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/04\/medicine_0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"665\" \/>\n\t<meta property=\"og:image:height\" content=\"320\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#\\\/schema\\\/person\\\/6310cfd59ccce9f9d4bc94d081892a84\"},\"headline\":\"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France.\",\"datePublished\":\"2014-12-10T15:32:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/\"},\"wordCount\":180,\"image\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/medicine_0.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/\",\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/\",\"name\":\"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France. - Universal Medica\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/medicine_0.jpg\",\"datePublished\":\"2014-12-10T15:32:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#\\\/schema\\\/person\\\/6310cfd59ccce9f9d4bc94d081892a84\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/medicine_0.jpg\",\"contentUrl\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/medicine_0.jpg\",\"width\":665,\"height\":320},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/\",\"name\":\"Universal Medica\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#\\\/schema\\\/person\\\/6310cfd59ccce9f9d4bc94d081892a84\",\"name\":\"Admin\",\"sameAs\":[\"http:\\\/\\\/universalmedica.agencekonig.com\"],\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France. - Universal Medica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France. - Universal Medica","og_description":"L\u2019ANSM lance une proc\u00e9dure de suspension, \u00e0 compter du 18 d\u00e9cembre, de 25 m\u00e9dicaments commercialis\u00e9s en France. Une inspection par l\u2019ANSM d\u2019un site de la soci\u00e9t\u00e9 GVK Bio qui r\u00e9alise des essais cliniques parmi lesquels des essais de bio\u00e9quivalence en Inde, a mis en \u00e9vidence des irr\u00e9gularit\u00e9s dans des documents associ\u00e9s \u00e0 ces essais sur [&hellip;]","og_url":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/","og_site_name":"Universal Medica","article_published_time":"2014-12-10T15:32:05+00:00","og_image":[{"width":665,"height":320,"url":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/04\/medicine_0.jpg","type":"image\/jpeg"}],"author":"Admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Admin","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/#article","isPartOf":{"@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/"},"author":{"name":"Admin","@id":"https:\/\/www.universalmedica.com\/fr\/#\/schema\/person\/6310cfd59ccce9f9d4bc94d081892a84"},"headline":"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France.","datePublished":"2014-12-10T15:32:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/"},"wordCount":180,"image":{"@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/#primaryimage"},"thumbnailUrl":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/04\/medicine_0.jpg","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/","url":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/","name":"L\u2019ANSM lance une proc\u00e9dure de suspension de 25 m\u00e9dicaments g\u00e9n\u00e9riques commercialis\u00e9s en France. - Universal Medica","isPartOf":{"@id":"https:\/\/www.universalmedica.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/#primaryimage"},"image":{"@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/#primaryimage"},"thumbnailUrl":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/04\/medicine_0.jpg","datePublished":"2014-12-10T15:32:05+00:00","author":{"@id":"https:\/\/www.universalmedica.com\/fr\/#\/schema\/person\/6310cfd59ccce9f9d4bc94d081892a84"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.universalmedica.com\/fr\/ansm-lance-procedure-suspension-25-medicaments-generiques-commercialises-en-france\/#primaryimage","url":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/04\/medicine_0.jpg","contentUrl":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2021\/04\/medicine_0.jpg","width":665,"height":320},{"@type":"WebSite","@id":"https:\/\/www.universalmedica.com\/fr\/#website","url":"https:\/\/www.universalmedica.com\/fr\/","name":"Universal Medica","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.universalmedica.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.universalmedica.com\/fr\/#\/schema\/person\/6310cfd59ccce9f9d4bc94d081892a84","name":"Admin","sameAs":["http:\/\/universalmedica.agencekonig.com"],"url":"https:\/\/www.universalmedica.com\/fr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/posts\/925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/comments?post=925"}],"version-history":[{"count":0,"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/posts\/925\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/media\/635"}],"wp:attachment":[{"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/media?parent=925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/categories?post=925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.universalmedica.com\/fr\/wp-json\/wp\/v2\/tags?post=925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}